menu
    • menu

    Company profile for Sentynl Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Sentynl Therapeutics is a biopharmaceutical company headquartered in the United States, dedicated to providing innovative therapies for patients suffering from rare diseases. Acquired by the Zydus Group in 2017, Sentynl benefits from the support and resources of a global healthcare conglomerate. At Sentynl, we prioritize ethical conduct and adhere strictly to all applicable laws, regulations, and industry standards. Our commit...
    Sentynl Therapeutics is a biopharmaceutical company headquartered in the United States, dedicated to providing innovative therapies for patients suffering from rare diseases. Acquired by the Zydus Group in 2017, Sentynl benefits from the support and resources of a global healthcare conglomerate. At Sentynl, we prioritize ethical conduct and adhere strictly to all applicable laws, regulations, and industry standards. Our commitment to upholding the highest ethical standards underscores our dedication to improving patient outcomes and advancing healthcare.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Sentynl TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Solana Beach, CA 92075
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://sentynl.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/sentynl-therapeutics-inc-/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Fortress Bio, Cyprium Therapeutics Update NDA For CUTX-101
    Fortress Bio, Cyprium Therapeutics Update NDA For CUTX-101

    01 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/01/3159486/28889/en/Fortress-Biotech-and-Cyprium-Therapeutics-Announce-an-Update-on-the-NDA-for-CUTX-101.html

    GLOBENEWSWIRE
    01 Oct 2025
    Share Share
    Er-Kim, Sentynl Therapeutics Partner On Nulibry & Zokinvy
    Er-Kim, Sentynl Therapeutics Partner On Nulibry & Zokinvy

    24 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/24/3155462/0/en/Er-Kim-Enters-Commercialization-Agreement-with-Sentynl-Therapeutics-for-Nulibry-fosdenopterin-and-Zokinvy-lonafarnib-Targeting-Ultra-Rare-Diseases.html

    GLOBENEWSWIRE
    24 Sep 2025
    Share Share
    Sentynl Therapeutics: Clinical Evidence for Nulibry in Molybdenum
    Sentynl Therapeutics: Clinical Evidence for Nulibry in Molybdenum

    04 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250404171911/en/Sentynl-Therapeutics-Announces-First-Comprehensive-Body-of-Clinical-Evidence-Supporting-NULIBRY-fosdenopterin-in-Treating-Molybdenum-Cofactor-Deficiency-Type-A-Compared-to-Natural-History

    BUSINESSWIRE
    04 Apr 2025
    Share Share
    Sentynl's CUTX-101 NDA Gets FDA Priority Review For Menkes Disease
    Sentynl's CUTX-101 NDA Gets FDA Priority Review For Menkes Disease

    06 Jan 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sentynl-therapeutics-announces-us-fda-acceptance-and-priority-review-of-new-drug-application-for-cutx-101-copper-histidinate-product-candidate-for-treatment-of-menkes-disease-302342403.html

    PR NEWSWIRE
    06 Jan 2025
    Share Share
    Sentynl Therapeutics Receives Great Place To Work® Certification
    Sentynl Therapeutics Receives Great Place To Work® Certification

    03 Jun 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sentynl-therapeutics-receives-great-place-to-work-certification-302161269.html

    PR NEWSWIRE
    03 Jun 2024
    Share Share
    Zydus unit acquires global rights to Eiger BioPharma’s Zokinvy
    Zydus unit acquires global rights to Eiger BioPharma’s Zokinvy

    06 May 2024

    // PHARMACEUTICAL TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/sentynl-acquires-eiger-zokinvy/#:~:text=Zydus%20Lifesciences%20subsidiary%20Sentynl%20Therapeutics,for%20the%20treatment%20of%20progeria.

    PHARMACEUTICAL TECHNOLOGY
    06 May 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search